1 |
Waanders E, Scheijen B, van der Meer LT et al (2012) The origin and nature of tightly clustered BTG1 deletions in precursor B-cell acute lymphoblastic leukemia support a model of multiclonal evolution. PLoS Genet 8, e1002533
|
2 |
Scheijen B, Boer JM, Marke R et al (2017) Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients. Haematologica 102, 541-551
DOI
|
3 |
Irving JA, Enshaei A, Parker CA et al (2016) Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia. Blood 128, 911-922
|
4 |
Chen Y, Wang C, Wu J and Li L (2015) BTG/Tob family members Tob1 and Tob2 inhibit proliferation of mouse embryonic stem cells via Id3 mRNA degradation. Biochem Biophys Res Commun 462, 208-214
DOI
|
5 |
Yoshida Y, Matsuda S, Ikematsu N et al (1998) ANA, a novel member of Tob/BTG1 family, is expressed in the ventricular zone of the developing central nervous system. Oncogene 16, 2687-2693
DOI
|
6 |
el-Ghissassi F, Valsesia-Wittmann S, Falette N, Duriez C, Walden PD and Puisieux A (2002) BTG2(TIS21/PC3) induces neuronal differentiation and prevents apoptosis of terminally differentiated PC12 cells. Oncogene 21, 6772-6778
DOI
|
7 |
Rouault JP, Rimokh R, Tessa C et al (1992) BTG1, a member of a new family of antiproliferative genes. EMBO J 11, 1663-1670
DOI
|
8 |
Miyata S, Mori Y and Tohyama M (2008) PRMT1 and Btg2 regulates neurite outgrowth of Neuro2a cells. Neurosci Lett 445, 162-165
DOI
|
9 |
Sasajima H, Nakagawa K, Kashiwayanagi M and Yokosawa H (2012) Polyubiquitination of the B-cell translocation gene 1 and 2 proteins is promoted by the SCF ubiquitin ligase complex containing betaTrCP. Biol Pharm Bull 35, 1539-1545
DOI
|
10 |
Park TJ, Kim JY, Park SH, Kim HS and Lim IK (2009) Skp2 enhances polyubiquitination and degradation of TIS21/BTG2/PC3, tumor suppressor protein, at the downstream of FoxM1. Exp Cell Res 315, 3152-3162
DOI
|
11 |
Evangelisti C, Astolfi A, Gaboardi GC et al (2009) TIS21/BTG2/PC3 and cyclin D1 are key determinants of nuclear diacylglycerol kinase-zeta-dependent cell cycle arrest. Cell Signal 21, 801-809
DOI
|
12 |
Coleman WB (2015) Genomic catastrophe and neoplastic transformation. Am J Pathol 185, 1846-1849
DOI
|
13 |
Fei JF, Haffner C and Huttner WB (2014) 3' UTR-dependent, miR-92-mediated restriction of Tis21 expression maintains asymmetric neural stem cell division to ensure proper neocortex size. Cell Rep 7, 398-411
DOI
|
14 |
Hong JW, Ryu MS and Lim IK (2005) Phosphorylation of serine 147 of tis21/BTG2/pc3 by p-Erk1/2 induces Pin-1 binding in cytoplasm and cell death. J Biol Chem 280, 21256-21263
DOI
|
15 |
Kim S, Hong JW and Park KW (2016) B cell translocation gene 2 (Btg2) is regulated by Stat3 signaling and inhibits adipocyte differentiation. Mol Cell Biochem 413, 145-153
DOI
|
16 |
Cho BO, Jeong YW, Kim SH et al (2008) Up-regulation of the BTG2 gene in TPA- or RA-treated HL-60 cell lines. Oncol Rep 19, 633-637
|
17 |
Hwang SS, Lim J, Yu Z et al (2020) mRNA destabilization by BTG1 and BTG2 maintains T cell quiescence. Science 367, 1255-1260
DOI
|
18 |
Hata K, Nishijima K and Mizuguchi J (2007) Role for Btg1 and Btg2 in growth arrest of WEHI-231 cells through arginine methylation following membrane immunoglobulin engagement. Exp Cell Res 313, 2356-2366
DOI
|
19 |
Cho JW, Kim JJ, Park SG et al (2004) Identification of B-cell translocation gene 1 as a biomarker for monitoring the remission of acute myeloid leukemia. Proteomics 4, 3456-3463
DOI
|
20 |
Lin WJ, Chang YF, Wang WL and Huang CY (2001) Mitogen-stimulated TIS21 protein interacts with a protein-kinase-Calpha-binding protein rPICK1. Biochem J 354, 635-643
DOI
|
21 |
Sasajima H, Nakagawa K and Yokosawa H (2002) Antiproliferative proteins of the BTG/Tob family are degraded by the ubiquitin-proteasome system. Eur J Biochem 269, 3596-3604
DOI
|
22 |
Micheli L, D'Andrea G, Leonardi L and Tirone F (2017) HDAC1, HDAC4, and HDAC9 bind to PC3/Tis21/Btg2 and are required for its inhibition of cell cycle progression and cyclin D1 expression. J Cell Physiol 232, 1696-1707
DOI
|
23 |
Guardavaccaro D, Corrente G, Covone F et al (2000) Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription. Mol Cell Biol 20, 1797-1815
DOI
|
24 |
Wheaton K, Muir J, Ma W and Benchimol S (2010) BTG2 antagonizes Pin1 in response to mitogens and telomere disruption during replicative senescence. Aging Cell 9, 747-760
DOI
|
25 |
Lim IK, Lee MS, Ryu MS et al (1998) Induction of growth inhibition of 293 cells by downregulation of the cyclin E and cyclin-dependent kinase 4 proteins due to overexpression of TIS21. Mol Carcinog 23, 25-35
DOI
|
26 |
Dolezal E, Infantino S, Drepper F et al (2017) The BTG2-PRMT1 module limits pre-B cell expansion by regulating the CDK4-Cyclin-D3 complex. Nat Immunol 18, 911-920
DOI
|
27 |
Chang BD, Swift ME, Shen M, Fang J, Broude EV and Roninson IB (2002) Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent. Proc Natl Acad Sci U S A 99, 389-394
DOI
|
28 |
Wei S, Hao C, Li X, Zhao H, Chen J and Zhou Q (2012) Effects of BTG2 on proliferation inhibition and anti-invasion in human lung cancer cells. Tumour Biol 33, 1223-1230
DOI
|
29 |
Stupfler B, Birck C, Seraphin B and Mauxion F (2016) BTG2 bridges PABPC1 RNA-binding domains and CAF1 deadenylase to control cell proliferation. Nat Commun 7, 10811
|
30 |
Mauxion F, Faux C and Seraphin B (2008) The BTG2 protein is a general activator of mRNA deadenylation. EMBO J 27, 1039-1048
DOI
|
31 |
Yan W, Li SX, Gao H and Yang W (2019) Identification of B-cell translocation gene 1-controlled gene networks in diffuse large B-cell lymphoma: a study based on bioinformatics analysis. Oncol Lett 17, 2825-2835
|
32 |
Zhang SQ, Yang Z, Cai XL et al (2017) miR-511 promotes the proliferation of human hepatoma cells by targeting the 3'UTR of B cell translocation gene 1 (BTG1) mRNA. Acta Pharmacol Sin 38, 1161-1170
DOI
|
33 |
Quy LN, Choi YW, Kim YH, Chwae YJ, Park TJ and Lim IK (2013) TIS21(/BTG2/PC3) inhibits interleukin-6 expression via downregulation of STAT3 pathway. Cell Signal 25, 2391-2399
DOI
|
34 |
He C, Yu T, Shi Y et al (2017) MicroRNA 301A promotes intestinal inflammation and colitis-associated cancer development by inhibiting BTG1. Gastroenterology 152, 1434-1448 e1415
|
35 |
Hunter ZR, Xu L, Yang G et al (2014) The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis. Blood 123, 1637-1646
DOI
|
36 |
Hu X, Xing L, Jiao Y et al (2013) BTG2 overexpression increases the radiosensitivity of breast cancer cells in vitro and in vivo. Oncol Res 20, 457-465
|
37 |
Pasqualucci L, Khiabanian H, Fangazio M et al (2014) Genetics of follicular lymphoma transformation. Cell Rep 6, 130-140
DOI
|
38 |
Kuo ML, Duncavage EJ, Mathew R et al (2003) Arf induces p53-dependent and -independent antiproliferative genes. Cancer Res 63, 1046-1053
|
39 |
Morin RD, Mendez-Lago M, Mungall AJ et al (2011) Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476, 298-303
DOI
|
40 |
De Falco G, Leucci E, Lenze D et al (2007) Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors. Blood 110, 1301-1307
DOI
|
41 |
Boiko AD, Porteous S, Razorenova OV, Krivokrysenko VI, Williams BR and Gudkov AV (2006) A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation. Genes Dev 20, 236-252
DOI
|
42 |
Reddy A, Zhang J, Davis NS et al (2017) Genetic and functional drivers of diffuse large B cell lymphoma. Cell 171, 481-494 e415
|
43 |
Nahta R, Yuan LX, Fiterman DJ et al (2006) B cell translocation gene 1 contributes to antisense Bcl-2-mediated apoptosis in breast cancer cells. Mol Cancer Ther 5, 1593-1601
DOI
|
44 |
Zhang Z, Chen C, Wang G et al (2011) Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins. Cell Biochem Biophys 61, 83-91
DOI
|
45 |
Choi OR, Ryu MS and Lim IK (2016) Shifting p53-induced senescence to cell death by TIS21(/BTG2/Pc3) gene through posttranslational modification of p53 protein. Cell Signal 28, 1172-1185
DOI
|
46 |
Wagener N, Bulkescher J, Macher-Goeppinger S et al (2013) Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients. Br J Cancer 108, 973-982
DOI
|
47 |
Kanda M, Oya H, Nomoto S et al (2015) Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer. Dig Dis Sci 60, 1256-1264
DOI
|
48 |
Yuniati L, van der Meer LT, Tijchon E et al (2016) Tumor suppressor BTG1 promotes PRMT1-mediated ATF4 function in response to cellular stress. Oncotarget 7, 3128-3143
DOI
|
49 |
Rouault JP, Falette N, Guehenneux F et al (1996) Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat Genet 14, 482-486
DOI
|
50 |
Kawakubo H, Brachtel E, Hayashida T et al (2006) Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein. Cancer Res 66, 7075-7082
DOI
|
51 |
Cortes U, Moyret-Lalle C, Falette N et al (2000) BTG gene expression in the p53-dependent and -independent cellular response to DNA damage. Mol Carcinog 27, 57-64
DOI
|
52 |
Prevot D, Voeltzel T, Birot AM et al (2000) The leukemia-associated protein Btg1 and the p53-regulated protein Btg2 interact with the homeoprotein Hoxb9 and enhance its transcriptional activation. J Biol Chem 275, 147-153
DOI
|
53 |
Busson M, Carazo A, Seyer P et al (2005) Coactivation of nuclear receptors and myogenic factors induces the major BTG1 influence on muscle differentiation. Oncogene 24, 1698-1710
DOI
|
54 |
Hu XD, Meng QH, Xu JY et al (2011) BTG2 is an LXXLL-dependent co-repressor for androgen receptor transcriptional activity. Biochem Biophys Res Commun 404, 903-909
DOI
|
55 |
Lin WJ, Gary JD, Yang MC, Clarke S and Herschman HR (1996) The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase. J Biol Chem 271, 15034-15044
DOI
|
56 |
Bedford MT and Clarke SG (2009) Protein arginine methylation in mammals: who, what, and why. Mol Cell 33, 1-13
DOI
|
57 |
Passeri D, Marcucci A, Rizzo G et al (2006) Btg2 enhances retinoic acid-induced differentiation by modulating histone H4 methylation and acetylation. Mol Cell Biol 26, 5023-5032
DOI
|
58 |
Tijchon E, van Emst L, Yuniati L et al (2016) Tumor suppressors BTG1 and BTG2 regulate early mouse B-cell development. Haematologica 101, e272-276
DOI
|
59 |
Aslam A, Mittal S, Koch F, Andrau JC and Winkler GS (2009) The Ccr4-NOT deadenylase subunits CNOT7 and CNOT8 have overlapping roles and modulate cell proliferation. Mol Biol Cell 20, 3840-3850
DOI
|
60 |
Venezia TA, Merchant AA, Ramos CA et al (2004) Molecular signatures of proliferation and quiescence in hematopoietic stem cells. PLoS Biol 2, e301
|
61 |
Konrad MA and Zuniga-Pflucker JC (2005) The BTG/TOB family protein TIS21 regulates stage-specific proliferation of developing thymocytes. Eur J Immunol 35, 3030-3042
DOI
|
62 |
Farioli-Vecchioli S, Micheli L, Saraulli D et al (2012) Btg1 is required to maintain the pool of stem and progenitor cells of the Dentate Gyrus and Subventricular Zone. Front Neurosci 6, 124
|
63 |
Zhu R, Zou ST, Wan JM, Li W, Li XL and Zhu W (2013) BTG1 inhibits breast cancer cell growth through induction of cell cycle arrest and apoptosis. Oncol Rep 30, 2137-2144
DOI
|
64 |
Farioli-Vecchioli S, Saraulli D, Costanzi M et al (2009) Impaired terminal differentiation of hippocampal granule neurons and defective contextual memory in PC3/Tis21 knockout mice. PLoS One 4, e8339
|